Pitcairn’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-68,827
| Closed | -$1.75M | – | 414 |
|
|
2025
Q3 | $1.75M | Buy |
68,827
+15,013
| +28% | +$371K | 0.14% | 132 |
|
|
2025
Q2 | $1.3M | Buy |
53,814
+22,158
| +70% | +$517K | 0.09% | 216 |
|
|
2025
Q1 | $802K | Buy |
31,656
+10,979
| +53% | +$287K | 0.05% | 307 |
|
|
2024
Q4 | $549K | Sell |
20,677
-5,592
| -21% | -$152K | 0.03% | 395 |
|
|
2024
Q3 | $760K | Sell |
26,269
-4,008
| -13% | -$117K | 0.04% | 320 |
|
|
2024
Q2 | $847K | Sell |
30,277
-5,851
| -16% | -$161K | 0.05% | 302 |
|
|
2024
Q1 | $1M | Buy |
36,128
+1,135
| +3% | +$31.5K | 0.07% | 261 |
|
|
2023
Q4 | $1.01M | Sell |
34,993
-2,921
| -8% | -$88.3K | 0.07% | 237 |
|
|
2023
Q3 | $1.26M | Sell |
37,914
-6,517
| -15% | -$230K | 0.11% | 176 |
|
|
2023
Q2 | $1.63M | Buy |
44,431
+1,916
| +5% | +$74.6K | 0.14% | 136 |
|
|
2023
Q1 | $1.73M | Sell |
42,515
-8,893
| -17% | -$384K | 0.16% | 125 |
|
|
2022
Q4 | $2.63M | Buy |
51,408
+5,741
| +13% | +$275K | 0.26% | 76 |
|
|
2022
Q3 | $2M | Sell |
45,667
-5,524
| -11% | -$268K | 0.22% | 95 |
|
|
2022
Q2 | $2.68M | Buy |
51,191
+6,100
| +14% | +$311K | 0.28% | 65 |
|
|
2022
Q1 | $2.33M | Buy |
45,091
+6,187
| +16% | +$321K | 0.2% | 93 |
|
|
2021
Q4 | $2.3M | Sell |
38,904
-1,524
| -4% | -$75.5K | 0.15% | 100 |
|
|
2021
Q3 | $1.74M | Sell |
40,428
-302
| -0.7% | -$13.4K | 0.12% | 122 |
|
|
2021
Q2 | $1.59M | Sell |
40,730
-853
| -2% | -$33.2K | 0.11% | 134 |
|
|
2021
Q1 | $1.51M | Sell |
41,583
-5,137
| -11% | -$182K | 0.11% | 136 |
|
|
2020
Q4 | $1.72M | Sell |
46,720
-7,928
| -15% | -$291K | 0.13% | 106 |
|
|
2020
Q3 | $1.9M | Buy |
54,648
+567
| +1% | +$19.9K | 0.16% | 90 |
|
|
2020
Q2 | $1.68M | Sell |
54,081
-8,636
| -14% | -$293K | 0.16% | 91 |
|
|
2020
Q1 | $1.94M | Buy |
62,717
+15,352
| +32% | +$523K | 0.23% | 66 |
|
|
2019
Q4 | $1.76M | Sell |
47,365
-2,197
| -4% | -$78.3K | 0.16% | 87 |
|
|
2019
Q3 | $1.69M | Sell |
49,562
-7,244
| -13% | -$263K | 0.17% | 82 |
|
|
2019
Q2 | $2.33M | Buy |
56,806
+4,410
| +8% | +$175K | 0.23% | 62 |
|
|
2019
Q1 | $2.11M | Sell |
52,396
-5,393
| -9% | -$216K | 0.23% | 61 |
|
|
2018
Q4 | $2.39M | Buy |
57,789
+12,001
| +26% | +$498K | 0.27% | 54 |
|
|
2018
Q3 | $1.91M | Buy |
45,788
+1,693
| +4% | +$65.2K | 0.2% | 66 |
|
|
2018
Q2 | $1.52M | Sell |
44,095
-1,544
| -3% | -$52.8K | 0.16% | 81 |
|
|
2018
Q1 | $1.54M | Sell |
45,639
-2,996
| -6% | -$103K | 0.16% | 83 |
|
|
2017
Q4 | $1.67M | Buy |
48,635
+4,163
| +9% | +$142K | 0.17% | 76 |
|
|
2017
Q3 | $1.51M | Sell |
44,472
-1,669
| -4% | -$53.6K | 0.17% | 80 |
|
|
2017
Q2 | $1.47M | Sell |
46,141
-14,404
| -24% | -$454K | 0.18% | 78 |
|
|
2017
Q1 | $1.97M | Buy |
60,545
+2,755
| +5% | +$86.9K | 0.24% | 58 |
|
|
2016
Q4 | $1.78M | Sell |
57,790
-3,153
| -5% | -$96.3K | 0.22% | 71 |
|
|
2016
Q3 | $1.96M | Buy |
60,943
+110
| +0.2% | +$3.68K | 0.24% | 59 |
|
|
2016
Q2 | $2.03M | Buy |
60,833
+14,283
| +31% | +$456K | 0.26% | 52 |
|
|
2016
Q1 | $1.31M | Sell |
46,550
-904
| -2% | -$25.8K | 0.17% | 102 |
|
|
2015
Q4 | $1.45M | Buy |
47,454
+1,935
| +4% | +$60.9K | 0.16% | 91 |
|
|
2015
Q3 | $1.36M | Sell |
45,519
-1,884
| -4% | -$60.4K | 0.18% | 88 |
|
|
2015
Q2 | $1.51M | Sell |
47,403
-7,511
| -14% | -$245K | 0.17% | 108 |
|
|
2015
Q1 | $1.81M | Sell |
54,914
-5,527
| -9% | -$176K | 0.2% | 95 |
|
|
2014
Q4 | $1.79M | Buy |
60,441
+2,103
| +4% | +$60.3K | 0.19% | 97 |
|
|
2014
Q3 | $1.64M | Sell |
58,338
-343
| -0.6% | -$9.63K | 0.18% | 102 |
|
|
2014
Q2 | $1.65M | Buy |
58,681
+1,916
| +3% | +$54.6K | 0.18% | 104 |
|
|
2014
Q1 | $1.73M | Sell |
56,765
-2,825
| -5% | -$84.2K | 0.19% | 95 |
|
|
2013
Q4 | $1.73M | Buy |
59,590
+3,189
| +6% | +$92.8K | 0.19% | 96 |
|
|
2013
Q3 | $1.54M | Sell |
56,401
-1,344
| -2% | -$36.6K | 0.19% | 102 |
|
|
2013
Q2 | $1.53M | Buy |
+57,745
| New | +$1.6M | 0.21% | 102 |
|
Other funds holding PFE
Pitcairn's PFE Position: Q4 2025 in Review
Pitcairn sold out of Pfizer (PFE) in Q4 2025, closing a stake of 68,827 shares — an estimated $1.75M sold.
Pitcairn first reported a position in PFE in Q2 2013 and held it in 50 quarters. The position peaked at $2.68M in Q2 2022. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Pitcairn reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Pitcairn sold 68,827 Pfizer shares in Q4 2025, an estimated $1.75M.
- Pitcairn first reported a position in Pfizer in Q2 2013 and held it in 50 quarters.
- Pitcairn's Pfizer position peaked at $2.68M in Q2 2022.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Pitcairn's 13F filing for Q4 2025.